Global Neurology Academy
The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
16-20 of 20
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
MinuteCE®Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
MinuteCE®Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
CME/CE Broadcast ReplayFactoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
CME/CEPatient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Global Neurology AcademyCladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
- advertisement
